AMCAL NICOTINE LOZENGES 2mg nicotine (as nicotine polacrilex) lozenge blister pack

Maa: Australia

Kieli: englanti

Lähde: Department of Health (Therapeutic Goods Administration)

Aktiivinen ainesosa:

nicotine polacrilex, Quantity: 13.33 mg (Equivalent: nicotine, Qty 2 mg)

Saatavilla:

Orion Laboratories Pty Ltd T/A Perrigo Australia

INN (Kansainvälinen yleisnimi):

Nicotine polacrilex

Lääkemuoto:

Tablet, uncoated

Koostumus:

Excipient Ingredients: mannitol; sodium carbonate; xanthan gum; potassium bicarbonate; sodium alginate; magnesium stearate; aspartame; Flavour

Antoreitti:

Buccal

Kpl paketissa:

120, 108, 96, 156, 36, 144, 132, 168, 72

Prescription tyyppi:

Not Scheduled after consideration by Committee

Käyttöaiheet:

Relief of nicotine withdrawal symptoms including cravings associated with smoking cessation. Nicotine Lozenges may also be used as part of a smoking reduction strategy by smokers who are unable or not ready to stop smoking abruptly as a step towards stopping smoking. If possible, when stopping smoking, should be used in conjunction with behavioural support program.

Tuoteyhteenveto:

Visual Identification: Cream/white embossed biconvex round tablet with an odour of peppermint. Embossed with 'L344' on one face.; Container Type: Blister Pack; Container Material: PVC/PCTFE (Aclar)/Al; Container Life Time: 36 Months; Container Temperature: Store below 25 degrees Celsius

Valtuutuksen tilan:

Licence status A

Valtuutus päivämäärä:

2013-08-15